Welcome to the ACGT web site

Welcome to this part of the ACGT site that is tailored to visitors from regulatory bodies in the life sciences space (such as EMEA in the EU and the FDA in the US) as well as those having a general interest in related issues.

This section aims to help you find information on how to benefit from ACGT research results as well as contribute to the ACGT community.

ACGT provides a grid based infrastructure together with an expanding set of data and software services resources for supporting life science practitioners in clinical trials and bio-research.

Information on the entire ACGT site is organized on the basis of stakeholder groups, regulatory bodies being one of these groups. For general information on ACGT please visit the main pages of the site. You may also visit the other stakeholder oriented pages for information aimed specifically at each of those groups.

Why is ACGT relevant to Regulatory Bodies?

Like pharmaceutical companies and bio-research organizations, Regulatory Bodies (RBs) ultimately aim promote the best possible health services for the public while at the same time ensuring the safety of all medicinal products and services that are offered in the market.

In this role RBs offer support materials (documentation, guidelines, protocols, standards etc.) that capture for the community the benefits of their unique vantage point due to access to confidential information and data that is not available to any single company or research organization, perform or sponsor their own research, as well as make use of advanced technologies and services that support their own needs.

Clinical trials have recently been recognized as an important bottleneck in the drug development process and therefore any knowledge, technologies or resources in general that will support and make clinical trials and related research more effective should be of interest to RBs.

In addition to supporting primary research and clinical trials in Breast Cancer and Wilm's Tumor, ACGT offers a number of important and useful resources (analytic software services, simulators, legal and ethical issues guidelines and expertise etc.) that are expected to be of significant interest to RBs.

The list below presents the broad topics on which you can access ACGT resources.

Legal/Ethical issues documents: includes a collection of documents covering developing legal/ethical issues in connection with life science and clinical trials research. [more...]
Research Results on Breast Cancer and Wilm's Tumor: includes scientific papers, data etc. that are published by ACGT researchers in connection with Breast cancer and Wilm's Tumor. [more...]
Clinical Trials Information: includes scientific papers, data etc. that are published by ACGT researchers in connection with the Breast cancer and Wilm's Tumor clinical trials. [more...]
Software services: lists services that can be accessed via the ACGT infrastructure and cover a variety of tasks and goals of interest to regulatory bodies. [more...]
Simulators: lists software simulators for various tasks. [more...]

For additional information that is not presently covered in the site, please send an email

Receive the ACGT Newsletter that keeps you up to date with the latest ACGT related developments by sending us an email.